Bakuchiol (BAK), isolated from the seeds of Psoralea corylifolia L., recently presents a variety of pharmacologic activities. However, the poor oral bioavailability limits its further development and clinical use. The purpose of this study was to establish a self-microemulsifying (SME) formulation for oral delivery improvement of BAK. The optimized liquid SME formulation was comprised of BAK (40 %), Cremophor RH 40 (30 %) and Labrasol (30 %). The emulsion droplets were spherical in shape, and particle size and zeta potential were determined. The in vitro dissolution test of BAK-SME formulation illustrated faster dissolution rate than the bulk drug. The permeabilities of 40 μg mL−1 BAK-SME formulation in rat intestinal segments of duodenum, jejunum, ileum and colon were 30.91 × 10−3, 23.61 × 10−3, 29.43 × 10−3 and 23.62 × 10−3 cm min−1, respectively, exhibiting 3.99 times in duodenum, 2.59 times in ileum and 2.31 times in colon greater than BAK perfusate. The oral bioavailability of BAK-SME formulation at a dose of 150 mg kg−1 was determined in rats. The Cmax and the AUC(0–24h) were 515.4 ng mL−1 and 4,327.2 h ng mL−1, respectively, which were 1.90 fold and 1.73 fold greater than the value of BAK suspension. All these results clearly stated that BAK-SME formulation performed well-improvement on oral bioavailability of BAK.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Adhikari, S., R. Joshi, B.S. Patro, T.K. Ghanty, G.J. Chintalwar, A. Sharma, S. Chattopadhyay, and T. Mukherjee. 2003. Antioxidant activity of bakuchiol: experimental evidences and theoretical treatments on the possible involvement of the terpenoid chain. Chemical Research in Toxicology 16: 1062–1069.
Bapat, K., G.J. Chintalwar, U. Pandey, V.S. Thakur, H.D. Sarma, G. Samuel, M.R. Pillai, S. Chattopadhyay, and M. Venkatesh. 2005. Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent. Applied Radiation and Isotopes 62: 389–393.
Chen, Z.Q., Y. Liu, J.H. Zhao, L. Wang, and N.P. Feng. 2012. Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system. International Journal of Nanomedicine 7: 1115–1125.
Chen, Z., K. Jin, L. Gao, G. Lou, Y. Jin, Y. Yu, and Y. Lou. 2010. Anti-tumor effects of bakuchiol, an analogue of resveratrol, on human lung adenocarcinoma A549 cell line. European Journal of Pharmacology 643: 170–179.
Cho, H., J.Y. Jun, E.K. Song, K.H. Kang, H.Y. Baek, Y.S. Ko, and Y.C. Kim. 2001. Bakuchiol: A hepatoprotective compound of Psoralea corylifolia on tacrine-induced cytotoxicity in Hep G2 cells. Planta Medica 67: 750–751.
Chopra, B., A.K. Dhingra, and K.L. Dhar. 2013. Psoralea corylifolia L. (Buguchi)—folklore to modern evidence: Review. Fitoterapia 90: 44–56.
Desai, P.P., A.A. Date, and V.B. Patravale. 2012. Overcoming poor oral bioavailability using nanoparticle formulations—opportunities and limitations. Drug Discovery Today 9: e87–e95.
Fagerholm, U., A. Lindahl, and H. Lennernas. 1997. Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms. Journal of Pharmacy and Pharmacology 49: 687–690.
Gao, X., Y. Yu, Y.J. Wang, J.X. Pi, W.L. Zhang, and X.Y. Xuan. 2013. Determination of equilibrium solubility and apparent oil/water partition coefficient of bakuchiol. West China Journal of Pharmaceutical Sciences 28: 285–286.
Guo, F., H. Zhong, J. He, B. Xie, F. Liu, H. Xu, M. Liu, and C. Xu. 2011. Self-microemulsifying drug delivery system for improved oral bioavailability of dipyridamole: Preparation and evaluation. Archives of Pharmacal Research 34: 1113–1123.
Haraguchi, H., J. Inoue, Y. Tamura, and K. Mizutani. 2000. Inhibition of mitochondrial lipid peroxidation by Bakuchiol, a meroterpene from Psoralea corylifolia. Planta Medica 66: 569–571.
Haraguchi, H., J. Inoue, Y. Tamura, and K. Mizutani. 2002. Antioxidative components of Psoralea corylifolia (Leguminosae). Phytotherapy Research 16: 539–544.
Hsu, P.J., J.S. Miller, and J.M. Berger. 2009. Bakuchiol, an antibacterial component of Psoralidium tenuiflorum. Natural Product Research 23: 781–788.
Jain, R., S. Duvvuri, V. Kansara, N.K. Mandava, and A.K. Mitra. 2007. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats. International Journal of Pharmaceutics 336: 233–240.
Kang, J.H., D.H. Oh, Y. Oh, C.S. Yong, and H. Choi. 2012. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). European Journal of Pharmaceutics and Biopharmaceutics 80: 289–297.
Katsura, H., R.I. Tsukiyama, A. Suzuki, and M. Kobayashi. 2001. In vitro antimicrobial activities of bakuchiol against oral microorganisms. Antimicrobial Agents and Chemotherapy 45: 3009–3013.
Kawabata, Y., K. Wada, M. Nakatani, S. Yamada, and S. Onoue. 2011. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. International Journal of Pharmaceutics 420: 1–10.
Khatune, N.A., M.E. Islam, M.E. Haque, P. Khondkar, and M.M. Rahman. 2004. Antibacterial compounds from the seeds of Psoralea corylifolia. Fitoterapia 75: 228–230.
Latha, P.G., D.A. Evans, K.R. Panikkar, and K.K. Jayavardhanan. 2000. Immunomodulatory and antitumour properties of Psoralea corylifolia seeds. Fitoterapia 71: 223–231.
Lau, K.M., L.H. Fu, L. Cheng, C.W. Wong, Y.L. Wong, C.P. Lau, S.Q. Han, P.K. Chan, K.P. Fung, C.B. Lau, M. Hui, and P.C. Leung. 2010. Two antifungal components isolated from Fructus Psoraleae and Folium Eucalypti Globuli by bioassay-guided purification. American Journal of Chinese Medicine 38: 1005–1014.
Lee, S.W., B.R. Yun, M.H. Kim, C.S. Park, W.S. Lee, H.M. Oh, and M.C. Rho. 2012. Phenolic compounds isolated from Psoralea corylifolia inhibit IL-6-induced STAT3 activation. Planta Medica 78: 903–906.
Li, S., Y. Liu, T. Liu, L. Zhao, J. Zhao, and N. Feng. 2011. Development and in vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique. International Journal of Pharmaceutics 411: 172–177.
Li, X., Q. Yuan, Y. Huang, Y. Zhou, and Y. Liu. 2010. Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability. AAPS PharmSciTech 11: 672–678.
Lim, S.H., T.Y. Ha, J. Ahn, and S. Kim. 2011. Estrogenic activities of Psoralea corylifolia L. seed extracts and main constituents. Phytomedicine 18: 425–430.
Lim, S.H., T.Y. Ha, S.R. Kim, J. Ahn, H.J. Park, and S. Kim. 2009. Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats. British Journal of Nutrition 101: 1031–1039.
Mohsin, K. 2012. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion. AAPS PharmSciTech 13: 637–646.
Pae, H.O., H. Cho, G.S. Oh, N.Y. Kim, E.K. Song, Y.C. Kim, Y.G. Yun, C.L. Kang, J.D. Kim, J.M. Kim, and H.T. Chung. 2001. Bakuchiol from Psoralea corylifolia inhibits the expression of inducible nitric oxide synthase gene via the inactivation of nuclear transcription factor-kappaB in RAW 264.7 macrophages. International Immunopharmacology 1: 1849–1855.
Park, E.J., Y.Z. Zhao, Y.C. Kim, and D.H. Sohn. 2005. Protective effect of (S)-bakuchiol from Psoralea corylifolia on rat liver injury in vitro and in vivo. Planta Medica 71: 508–513.
Reis, J.M., A.B. Dezani, T.M. Pereira, A. Avdeef, and C.H. Serra. 2013. Lamivudine permeability study: a comparison between PAMPA, ex vivo and in situ single-pass intestinal perfusion (SPIP) in rat jejunum. European Journal of Pharmaceutical Sciences 48: 781–789.
Seo, E., Y.S. Oh, D. Kim, M.Y. Lee, S. Chae, and H.S. Jun. 2013. Protective role of Psoralea corylifolia L. seed extract against hepatic mitochondrial dysfunction induced by oxidative stress or aging. Evidence Based Complementary and Alternative Medicine 2013: 678028.
Sha, X., G. Yan, Y. Wu, J. Li, and X. Fang. 2005. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. European Journal of Pharmaceutical Sciences 24: 477–486.
Shen, Y., Y. Lu, M. Jv, J. Hu, Q. Li, and J. Tu. 2011. Enhancing effect of Labrasol on the intestinal absorption of ganciclovir in rats. Drug Development and Industrial Pharmacy 37: 1415–1421.
Shui, M., J. Andrew, and J. Christopher. 1998. Formulation design and bioavailability assessment of lipidic self-emulsifying formulation of halofantrine. International Journal of Pharmaceutics 167: 155–164.
Singh, A.K., A. Chaurasiya, A. Awasthi, G. Mishra, D. Asati, R.K. Khar, and R. Mukherjee. 2009. Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech 10: 906–916.
Sun, M., X. Zhai, K. Xue, L. Hu, X. Yang, G. Li, and L. Si. 2011. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. European Journal of Pharmaceutical Sciences 43: 132–140.
Ujhelyi, Z., F. Fenyvesi, J. Varadi, P. Feher, T. Kiss, S. Veszelka, M. Deli, M. Vecsernyes, and I. Bacskay. 2012. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer. European Journal of Pharmaceutical Sciences 47: 564–573.
Venkatesh, G., M.I. Majid, S.M. Mansor, N.K. Nair, S.L. Croft, and V. Navaratnam. 2010. In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone. Drug Development and Industrial Pharmacy 36: 735–745.
Wang, D., F. Li, and Z. Jiang. 2001. Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Medica 67: 748–749.
Wang, Y., J. Sun, T. Zhang, H. Liu, F. He, and Z. He. 2011. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Drug Development and Industrial Pharmacy 37: 1225–1230.
Woo, J.S., T.S. Kim, J.H. Park, and S.C. Chi. 2007. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS. Archives of Pharmacal Research 30: 82–89.
Xin, D., H. Wang, J. Yang, Y.F. Su, G.W. Fan, Y.F. Wang, Y. Zhu, and X.M. Gao. 2010. Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity. Phytomedicine 17: 126–131.
Yan, D.M., Y.X. Chang, Y.F. Wang, E.W. Liu, J. Li, L.Y. Kang, and X.M. Gao. 2010. In vivo pharmacokinetics of bakuchiol after oral administration of bakuchiol extraction in rat plasma. Journal of Ethnopharmacology 128: 697–702.
Zhang, Y., Q.S. Wang, Y.L. Cui, F.C. Meng, and K.M. Lin. 2012. Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins. International Journal of Nanomedicine 7: 4239–4249.
Zhuang, X., Y. Zhong, M. Yuan, and H. Li. 2013. Pre-column derivatization combined with UHPLC-MS/MS for rapid and sensitive quantification of bakuchiol in rat plasma. Journal of Pharmaceutical and Biomedical Analysis 75: 18–24.
This study was financially supported by National Key Technology Research and Development Program of China (2012ZX09304007).
Conflict of interest
The authors report no conflict of interest.
About this article
Cite this article
Pi, J., Gao, X., Yu, Y. et al. Self-micro emulsifying formulation improved intestinal absorption and oral bioavailability of bakuchiol. Arch. Pharm. Res. (2014). https://doi.org/10.1007/s12272-014-0499-x
- SME formulation
- Oral bioavailability
- Intestinal absorption